查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018831

内视镜设备市场：2026-2032年全球市场预测（以内视镜类型、应用、用途、最终用户和通路划分）

Endoscopy Devices Market by Endoscope Type, Application, Usage Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，内视镜设备市场价值将达到 506.1 亿美元，到 2026 年将成长至 543.3 亿美元，到 2032 年将达到 834.9 亿美元，复合年增长率为 7.41%。

主要市场统计数据
基准年 2025 506.1亿美元
预计年份：2026年 543.3亿美元
预测年份 2032 834.9亿美元
复合年增长率 (%) 7.41%

权威概述了临床需求、技术进步和采购重点如何改变现代内视镜设备的市场结构。

内视镜设备领域处于临床需求、技术创新和复杂供应链动态的交会点。近年来，临床医生对高解析度成像、微创诊断和治疗方法以及能够降低感染风险并简化工作流程的一次性耗材提出了更高的要求。同时，光学、感测器小型化、机器人技术和软体主导的可视化技术的进步拓展了临床应用范围，并重新定义了操​​作标准。这些变化使得内视镜的功能从最初的诊断扩展到多学科的治疗和混合应用。

技术进步、对感染预防的日益重视以及供应链的重组，都在促使整个内视镜市场发生深刻的结构性变化。

内视镜产业正经历一场变革性的转型，技术、临床和市场因素的整合正在重塑手术流程和供应模式。首先，影像技术的稳定成熟以及人工智慧（AI）在诊断影像中的应用，使得早期诊断更加精准，同时也促进了微创治疗性介入。这些进步提升了胶囊内视镜、软式影像内视镜和硬式内视镜在更广泛适应症的临床效用。其次，对感染预防的持续关注加速了一次性内视镜的普及，同时也推动了可重复使用内视镜系统的高级消毒和再处理流程的改进，从而形成了既竞争又共存的平行产品管道。

评估 2025 年美国对内视镜产业征收关税对采购、筹资策略和供应链韧性的多面向影响。

2025年新关税措施的实施进一步加剧了内视镜设备製造商、契约製造製造商和设备零件供应商的全球筹资策略的复杂性。关税政策可能会影响成像感测器、光学组件、光源和电子控制模组的总成本，而这些组件通常透过国际供应链网路采购。在贸易壁垒日益加深的背景下，采购团队正在加强对近岸外包、双重采购和策略性库存管理策略的评估，以降低关税和运输成本波动带来的风险。同时，供应商和原始设备製造商（OEM）也正在重新评估合约条款，以确定是将额外成本转嫁给客户还是自行承担课税，从而保持竞争优势。

透过对设备类型、临床应用、使用模式、最终用户和分销管道进行详细的細項分析，可以揭示可操作的策略见解。

一套精细的市场细分框架揭示了每种产品类别、临床应用、使用模式、最终用户和分销管道的不同市场进入曲线和投资重点。基于内视镜类型，市场细分为胶囊内视镜、软式内视镜和硬式内视镜，每种内视镜在可视化、操作和治疗整合方面各有优势，并需要不同的维护和消毒流程。基于应用，市场细分为关节镜、胃肠内视镜检查、腹腔镜检查和泌尿系统内视镜检查。关节镜类别进一步细分为髋关节内视镜检查、膝关节内关节镜和肩关节关节镜，反映了对专用器材和诊断影像的需求。在胃肠内视镜检查领域，分析涵盖大肠镜检查、内视镜超音波、ERCP 和胃镜检查，揭示了不同诊断和治疗功能在装置需求和配套系统方面的差异。腹腔镜领域进一步细分，并按普通腹腔镜、妇科腹腔镜和儿童腹腔镜进行详细研究，重点关注其在尺寸、人体工学和照明方面的差异。在泌尿系统内视镜领域，膀胱结石碎石术、膀胱镜检查和输尿管镜检查也进行了更深入的研究，这些检查在入路、能量供应和灌注管理方面存在差异。

了解区域临床重点、报销结构和製造地如何影响全球内视镜市场采用模式的差异。

区域趋势对全球内视镜市场的采用模式、监管考量和竞争策略有显着影响。在美洲，大规模医院网路、成熟的门诊手术体係以及支付方对手术能力和感染控制的重视，正深刻地影响市场需求。这些因素推动了对高性能软式内视镜、特定环境下的一次性内视镜以及整合式成像平台的强劲需求。在欧洲和中东及非洲，不同的管理体制和采购结构导致了不同的采用模式。一些市场优先考虑集中采购和基于价值的合同，而另一些市场则专注于私人门诊机构的发展，这为模组化和可配置解决方案创造了区域差异化的机会。在亚太地区，医疗基础设施的快速扩张、手术量的增加以及对微创技术的日益关注，推动了对经济高效、可重复使用系统和创新型一次性内视镜设计的需求，同时也提升了本地製造地和区域供应商的战略重要性。

在内视镜领域，成熟企业、创新者和服务伙伴如何透过平台策略、临床证据产生和伙伴关係进行协作，从而有效地展开竞争？

内视镜领域的竞争动态取决于规模经济、平台创新和服务卓越三者之间的平衡。拥有成熟手术和大型设备产品组合的医疗设备製造商凭藉其广泛的临床关係、完善的服务网络和丰富的监管经验，在软式和硬式内视镜等关键领域保持领先地位。同时，专业公司和Start-Ups透过在胶囊内视镜技术、一次性内视镜、先进成像感测器和人工智慧视觉化工具等领域推出针对性创新，挑战着传统的价值提案。这些新参与企业通常采用基于最小资产的商业化模式，并与契约製造和当地分销商合作，以加速市场进入。

为市场领导提供切实可行的策略性倡议，以增强供应韧性，加速在临床环境中的应用，并透过服务和证据实现差异化。

产业领导者可以透过采取切实可行的多面向策略，将市场复杂性转化为机会，这些策略旨在满足临床需求、确保供应连续性并实现商业性差异化。首先，优先考虑模组化产品架构和供应商多元化，以降低单一供应商带来的风险，并在贸易政策或物流中断时实现快速零件更换。其次，加速临床证据项目，量化效率提升、感染控制效益和治疗效果，从而缩短采购评估週期，并加强基于价值的采购对话。第三，透过针对门诊手术中心、医院和专科诊所调整特定产品配置，建立清晰的市场细分，以反映处理能力、预算週期和临床工作流程的差异。

为了支持策略建议，我们采用了严谨的混合研究途径，结合了临床医生的第一手资料、第二手检验和三角测量分析。

本研究采用混合方法，整合了与一手专家的对话、结构化的二手资料分析以及多方面的检验，以确保获得可靠且可操作的见解。一手资讯透过与临床医生、医院系统和门诊手术中心的采购经理、监管专家以及行业高管的深入访谈收集，以了解实际限制、未满足的临床需求以及推广应用的障碍。二手资料分析利用同行评审的临床文献、监管文件、专利趋势以及公开的企业资讯披露，检验技术进步和竞争地位。资料三角验证透过交叉引用供应商访谈、最终用户回馈和监管文件，整合了不同的观点。

全面概述如何协调创新、临床检验和供应链韧性，以在不断变化的内视镜医学领域中获得策略优势。

总之，内视镜设备生态系统正处于一个转折点，技术进步和不断演进的医疗服务模式与供应链和政策的阻力交织在一起。儘管不断扩展的成像能力、人工智慧成像技术以及日益增多的微创治疗方案正在改变临床实践，但感染控制、成本控制和受关税驱动的采购决策等压力也在影响着商业策略。这些因素既带来了挑战，也带来了机会。能够快速整合产品设计、临床证据产生和灵活生产能力的製造商将超越那些依赖传统模式的竞争对手。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 内视镜设备市场：以内视镜类型划分

  • 胶囊内视镜
  • 软式内视镜
  • 硬式内视镜

第九章 内视镜设备市场：依应用领域划分

  • 关节镜
    • 髋关节镜检查
    • 膝关节关节镜
    • 肩关节关节镜
  • 胃肠内视镜检查
    • 大肠镜检查
    • 内视镜超音波
    • ERCP
    • 胃镜检查
  • 腹腔镜
    • 普通腹腔镜
    • 妇科腹腔镜
    • 儿童腹腔镜手术
  • 泌尿系统视镜检查
    • 膀胱结石体外震波碎石术
    • 膀胱镜检查
    • 输尿管镜检查

第十章 内视镜设备市场依应用领域划分

  • 可重复使用的内视镜
  • 免洗内视镜

第十一章 内视镜设备市场：依最终用户划分

  • 日间手术中心
  • 医院
  • 专科诊所

第十二章 内视镜设备市场：依通路划分

  • 直销
  • 透过分销商销售

第十三章 内视镜设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 内视镜设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 内视镜设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国内视镜设备市场

第十七章：中国内视镜设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ambu A/S
  • Asensus Surgical, Inc.
  • Auris Health, Inc.
  • avateramedical GmbH
  • Boston Scientific Corporation
  • Brainlab AG
  • CMR Surgical Ltd.
  • Conmed Corporation
  • Cook Group Incorporated
  • Endocontrol SA by Canady Life Sciences, Inc.
  • EndoMaster Pte Ltd
  • Endotics
  • FUJIFILM Holdings Corporation
  • Globus Medical, Inc.
  • HOYA Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Olympus Corporation
  • Otsuka Holdings Co., Ltd.
  • Renishaw PLC
  • Smith & Nephew plc
  • Stryker Corporation
  • Virtuoso Surgical, Inc.
Product Code: MRR-ED54C46E8C23

The Endoscopy Devices Market was valued at USD 50.61 billion in 2025 and is projected to grow to USD 54.33 billion in 2026, with a CAGR of 7.41%, reaching USD 83.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 50.61 billion
Estimated Year [2026] USD 54.33 billion
Forecast Year [2032] USD 83.49 billion
CAGR (%) 7.41%

An authoritative overview of how clinical demand, technological advances, and procurement priorities are reshaping the modern endoscopy devices landscape

The field of endoscopy devices sits at the intersection of clinical necessity, technological innovation, and complex supply chain dynamics. In recent years clinicians have demanded higher-resolution imaging, less invasive diagnostic and therapeutic approaches, and disposable options that reduce infection risk and streamline workflow. Simultaneously, technological progress in optics, sensor miniaturization, robotics, and software-driven visualization has expanded clinical capabilities and reshaped procedural standards. These shifts have elevated endoscopy from primarily diagnostic roles into therapeutic and hybrid applications across multiple specialties.

Meanwhile, health systems and outpatient providers emphasize efficiency, throughput, and total cost of care, prompting procurement teams to weigh lifecycle maintenance against single-use convenience. New regulatory scrutiny and growing emphasis on post-market surveillance have further influenced product design and commercialization strategies. As a result, manufacturers, hospital systems, and policy-makers navigate a rapidly evolving ecosystem where clinical outcomes, economic constraints, and innovation cycles converge. This introduction frames the broader landscape and sets expectations for subsequent sections that analyze transformative shifts, tariff impacts, segmentation nuances, regional dynamics, competitor behavior, recommended actions, methodological rigor, and concluding perspectives.

How converging technological advances, infection prevention priorities, and supply chain realignments are driving deep structural change across endoscopy markets

The endoscopy landscape is undergoing transformative shifts driven by converging technological, clinical, and market forces that are redefining procedure paradigms and supply models. First, the steady maturation of imaging technologies and integration of artificial intelligence into image interpretation are enabling earlier and more accurate diagnoses while facilitating minimally invasive therapeutic interventions. These advances increase the clinical utility of capsule systems, flexible video endoscopes, and rigid scopes across a wider set of indications. Second, the persistent focus on infection prevention has accelerated uptake of single use endoscopes alongside improvements in high-level disinfection and reprocessing protocols for reusable systems, thereby creating parallel product pathways that compete and coexist.

Third, procedural migration from inpatient operating rooms to ambulatory surgery centers and specialty clinics is reshaping workflow expectations and device form factors, prompting manufacturers to optimize for portability, sterilization ease, and rapid turnover. Fourth, supply chain localization, strategic component sourcing, and heightened regulatory scrutiny are forcing organizations to re-evaluate supplier relationships and manufacturing footprints. Lastly, new entrants and cross-sector collaborations are introducing modular platforms, software-as-a-service offerings, and integrated procedural suites that compel incumbents to move faster on partnerships and platform strategies. Together, these shifts are not incremental; they form a composite of disruptive trends that will influence product roadmaps, go-to-market models, and clinical adoption curves over the coming years.

Assessing the multifaceted consequences of 2025 United States tariff actions on procurement, sourcing strategies, and supply chain resilience in endoscopy

The introduction of new tariff measures in 2025 has introduced additional complexity into global sourcing strategies for endoscopy device manufacturers, contract manufacturers, and device component suppliers. Tariff policy can influence the landed cost of imaging sensors, optics assemblies, light sources, and electronic control modules that are frequently sourced across international supply networks. As trade barriers rise, procurement teams increasingly evaluate nearshoring, dual-sourcing, and strategic inventory policies to mitigate exposure to customs duties and transportation volatility. In parallel, suppliers and OEMs reassess contractual terms to pass through incremental cost or to absorb levies as part of competitive positioning.

Beyond direct cost implications, tariffs alter supplier bargaining power and can lengthen qualification timelines for alternate vendors. This dynamic affects product launch schedules and can delay clinical rollouts when critical components are tied to specific suppliers. Moreover, tariff-driven shifts interact with regulatory and reimbursement environments, creating cascading effects on pricing strategies, contract negotiations with health systems, and decisions about product modularity to allow for variant sourcing. To manage these cumulative impacts, industry players are prioritizing scenario planning, enhancing visibility into multi-tier supply chains, and accelerating investments in localized manufacturing capacity where feasible. These responses aim to preserve clinical availability, control total landed cost, and maintain competitive differentiation despite a more fragmented global trade environment.

Detailed segmentation analysis linking device typologies, clinical applications, usage models, end users, and distribution channels to reveal practical strategic insights

A nuanced segmentation framework reveals distinct adoption curves and investment priorities across product classes, clinical applications, usage models, end users, and distribution channels. Based on Endoscope Type, the market is studied across Capsule Endoscopes, Flexible Endoscopes, and Rigid Endoscopes, each offering differing capabilities for visualization, access, and therapeutic integration and requiring tailored service and sterilization protocols. Based on Application, the market is studied across Arthroscopy, Gastrointestinal Endoscopy, Laparoscopy, and Urological Endoscopy; the Arthroscopy category is further studied across Hip Arthroscopy, Knee Arthroscopy, and Shoulder Arthroscopy, reflecting specialized instrumentation and imaging needs. Within Gastrointestinal Endoscopy, the analysis covers Colonoscopy, Endoscopic Ultrasound, ERCP, and Gastroscopy, highlighting how diagnostic and interventional functions diverge in device requirements and accessory ecosystems. The Laparoscopy segment is further studied across General Laparoscopy, Gynecological Laparoscopy, and Pediatric Laparoscopy, emphasizing size, ergonomics, and illumination differences. The Urological Endoscopy segment is further studied across Cystolithotripsy, Cystoscopy, and Ureteroscopy, which vary by channel access, energy delivery, and irrigation management.

Based on Usage Type, the market is studied across Reusable Endoscopes and Single Use Endoscopes, an axis that captures the trade-offs between capital investment, reprocessing infrastructure, cross-infection risk, and per-procedure economics. Based on End User, the market is studied across Ambulatory Surgery Centers, Hospitals, and Specialty Clinics, each exhibiting different purchasing cycles, procedural volumes, and staffing models that influence device selection. Based on Distribution Channel, the market is studied across Direct Sales and Distributor Sales, which correspond to manufacturer control over pricing, service relationships, and market reach. Together, these segmentation lenses provide a comprehensive map for understanding where clinical need, economic drivers, and commercial execution intersect to create differentiated opportunities and risks.

Understanding how regional clinical priorities, reimbursement structures, and manufacturing footprints drive divergent adoption patterns across global endoscopy markets

Regional dynamics materially influence adoption patterns, regulatory considerations, and competitive strategies across the global endoscopy landscape. In the Americas, demand is strongly shaped by large hospital networks, a mature outpatient surgical ecosystem, and payer dynamics that prioritize procedural throughput and infection control; these drivers translate into robust demand for high-performance flexible endoscopes, disposable options in select settings, and integrated imaging platforms. In Europe, Middle East & Africa, diverse regulatory regimes and purchasing structures lead to heterogeneous adoption; some markets favor centralized procurement and value-based contracting while others emphasize private ambulatory growth, creating a patchwork of opportunities for modular and configurable solutions. In the Asia-Pacific region, rapid expansion of healthcare infrastructure, growing procedural volumes, and a rising emphasis on minimally invasive techniques are fueling interest in both cost-efficient reusable systems and innovative single use designs, while local manufacturing footprints and regional suppliers are gaining strategic importance.

Across regions, the pace of technology adoption correlates with clinical training availability, reimbursement incentives, and supply chain maturity. Consequently, manufacturers must tailor regulatory strategies, service models, and pricing approaches to address regional variations in hospital procurement, ambulatory center proliferation, and specialty clinic expansion. In addition, cross-border trade policies and regional manufacturing investments will continue to shape where companies locate assembly, final testing, and after-sales support to optimize responsiveness to clinicians and healthcare purchasers.

How incumbents, innovators, and service partners are converging on platform strategies, clinical evidence generation, and partnerships to compete effectively in endoscopy

Competitive dynamics in endoscopy hinge on a balance between scale-based advantages, platform innovation, and service excellence. Incumbent medical device manufacturers with established surgical and capital equipment portfolios often leverage broad clinical relationships, integrated service networks, and regulatory experience to maintain leadership in core segments such as flexible and rigid endoscopes. At the same time, specialist firms and startups are introducing targeted innovations in capsule technology, single use scopes, advanced imaging sensors, and AI-enabled visualization tools that challenge traditional value propositions. These entrants frequently adopt asset-light commercialization models and partner with contract manufacturers or local distributors to accelerate market entry.

Strategic partnerships and M&A continue to be important mechanisms for incumbents to fill technological gaps, acquire niche capabilities, or expand into adjacent therapeutic areas. In parallel, supply chain partners and third-party reprocessors are reshaping total cost of ownership debates by offering alternative servicing models and warranty structures. To sustain competitive advantage, companies are prioritizing investments in digital ecosystems, clinical evidence generation, and training programs that reduce adoption friction. Equally important is the ability to demonstrate outcomes, safety, and efficiency improvements in real-world settings, as purchasing committees increasingly demand data-driven justification for capital and consumable selection. Overall, the market rewards firms that can align technological differentiation with scalable commercial execution and strong clinical validation.

Actionable strategic initiatives for market leaders to fortify supply resilience, accelerate clinical adoption, and differentiate through service and evidence

Industry leaders can translate market complexity into opportunity by adopting a pragmatic, multidimensional strategy that addresses clinical needs, supply continuity, and commercial differentiation. First, prioritize modular product architectures and supplier diversification to reduce single-source risk and enable rapid component substitution when trade policy or logistics disruptions occur. Second, accelerate clinical evidence programs that quantify efficiency gains, infection control benefits, and procedural outcomes, thereby shortening procurement evaluation cycles and reinforcing value-based purchasing conversations. Third, develop clear go-to-market segmentation by aligning specific product configurations with Ambulatory Surgery Centers, Hospitals, and Specialty Clinics to reflect differences in throughput, budget cycles, and clinical workflows.

Fourth, invest in flexible service models that combine remote diagnostics, predictive maintenance, and outcome-linked support to improve device uptime and reduce total cost of care for end users. Fifth, evaluate selective localization or nearshoring for critical subassemblies to mitigate tariff exposure while preserving cost competitiveness. Sixth, pursue partnerships and co-development agreements to accelerate access to AI, robotic, and sensor innovations without incurring full internal development overhead. Finally, embed a regulatory and reimbursement intelligence function within strategic planning to anticipate policy shifts and to adapt product labeling, clinical trial design, and market access tactics proactively. Implementing these recommendations can help leaders convert disruption into differentiation and build resilient growth pathways.

A rigorous hybrid research approach combining primary clinician insights, secondary validation, and triangulated analysis to underpin strategic recommendations

This research employs a hybrid methodology that integrates primary expert engagement, structured secondary analysis, and multi-source triangulation to ensure robust, actionable findings. Primary inputs include in-depth discussions with practicing clinicians, procurement leaders across hospital systems and ambulatory centers, regulatory specialists, and industry executives to capture real-world operational constraints, unmet clinical needs, and adoption barriers. Secondary analysis draws on peer-reviewed clinical literature, regulatory filings, patent landscapes, and publicly reported corporate disclosures to validate technology trajectories and competitive positioning. Data triangulation reconciles divergent perspectives by cross-referencing supplier interviews with end-user feedback and regulatory documentation.

Analytical processes include segmentation mapping across product type, application, usage model, end user, and distribution channel, along with scenario analysis that examines supply chain, policy, and technology perturbations. Quality assurance procedures encompass source verification, expert panel review, and consistency checks across chapters to maintain interpretive integrity. Where relevant, methodological notes outline limitations, such as the evolving nature of tariff policy and the pace of clinical adoption, and indicate areas where ongoing monitoring will be beneficial. The result is a structured body of evidence designed to support strategic planning, procurement decision-making, and R&D prioritization while acknowledging inherent uncertainties in a dynamic market.

Closing perspectives on aligning innovation, clinical validation, and supply resilience to capture strategic advantage in an evolving endoscopy landscape

In conclusion, the endoscopy devices ecosystem is at an inflection point where technological progress and changing care delivery models are intersecting with supply chain and policy headwinds. The expansion of imaging capabilities, AI-assisted interpretation, and minimally invasive therapeutic options is transforming clinical practice, while parallel pressures around infection control, cost containment, and tariff-driven sourcing decisions shape commercial strategy. These forces create both tension and opportunity: manufacturers that can rapidly align product design, clinical evidence generation, and flexible manufacturing will outpace competitors that rely on legacy models.

Looking ahead, successful stakeholders will be those who integrate rigorous scenario planning into procurement and product roadmaps, partner strategically to complement internal capabilities, and maintain a disciplined focus on outcomes that matter to clinicians and payers. By synthesizing segmentation-specific insights with regional realities and supply chain considerations, decision-makers can identify targeted investments that enhance resilience, accelerate adoption, and preserve margins. The conclusion underscores a pragmatic imperative: anticipate change proactively, validate innovations in real-world settings, and structure commercial models to capture value across an increasingly complex and opportunity-rich endoscopy landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopy Devices Market, by Endoscope Type

  • 8.1. Capsule Endoscopes
  • 8.2. Flexible Endoscopes
  • 8.3. Rigid Endoscopes

9. Endoscopy Devices Market, by Application

  • 9.1. Arthroscopy
    • 9.1.1. Hip Arthroscopy
    • 9.1.2. Knee Arthroscopy
    • 9.1.3. Shoulder Arthroscopy
  • 9.2. Gastrointestinal Endoscopy
    • 9.2.1. Colonoscopy
    • 9.2.2. Endoscopic Ultrasound
    • 9.2.3. ERCP
    • 9.2.4. Gastroscopy
  • 9.3. Laparoscopy
    • 9.3.1. General Laparoscopy
    • 9.3.2. Gynecological Laparoscopy
    • 9.3.3. Pediatric Laparoscopy
  • 9.4. Urological Endoscopy
    • 9.4.1. Cystolithotripsy
    • 9.4.2. Cystoscopy
    • 9.4.3. Ureteroscopy

10. Endoscopy Devices Market, by Usage Type

  • 10.1. Reusable Endoscopes
  • 10.2. Single Use Endoscopes

11. Endoscopy Devices Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Endoscopy Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales

13. Endoscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoscopy Devices Market

17. China Endoscopy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Ambu A/S
  • 18.6. Asensus Surgical, Inc.
  • 18.7. Auris Health, Inc.
  • 18.8. avateramedical GmbH
  • 18.9. Boston Scientific Corporation
  • 18.10. Brainlab AG
  • 18.11. CMR Surgical Ltd.
  • 18.12. Conmed Corporation
  • 18.13. Cook Group Incorporated
  • 18.14. Endocontrol SA by Canady Life Sciences, Inc.
  • 18.15. EndoMaster Pte Ltd
  • 18.16. Endotics
  • 18.17. FUJIFILM Holdings Corporation
  • 18.18. Globus Medical, Inc.
  • 18.19. HOYA Corporation
  • 18.20. Intuitive Surgical, Inc.
  • 18.21. Johnson & Johnson
  • 18.22. Karl Storz SE & Co. KG
  • 18.23. Medtronic plc
  • 18.24. MicroPort Scientific Corporation
  • 18.25. Olympus Corporation
  • 18.26. Otsuka Holdings Co., Ltd.
  • 18.27. Renishaw PLC
  • 18.28. Smith & Nephew plc
  • 18.29. Stryker Corporation
  • 18.30. Virtuoso Surgical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HIP ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HIP ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HIP ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY KNEE ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY KNEE ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY KNEE ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SHOULDER ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SHOULDER ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SHOULDER ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY COLONOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY COLONOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPIC ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPIC ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPIC ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ERCP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ERCP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY ERCP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GASTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GENERAL LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GENERAL LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GENERAL LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GYNECOLOGICAL LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GYNECOLOGICAL LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GYNECOLOGICAL LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRIC LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRIC LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY PEDIATRIC LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOLITHOTRIPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOLITHOTRIPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOLITHOTRIPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY CYSTOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY URETEROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. GCC ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. GCC ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 190. GCC ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. GCC ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. GCC ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. G7 ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. G7 ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 219. G7 ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 220. G7 ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. G7 ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. G7 ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. NATO ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 229. NATO ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. NATO ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY LAPAROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY UROLOGICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY USAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)